Orthex Oyj
Orthex Oyj is a Finnish company that produces and sells chemical products, primarily serving the industrial and consumer goods sectors.
Business. Orthex Oyj (ORTHEX.HE) is a Finnish company operating in the commodity chemicals industry within the broader chemicals sector. The firm is headquartered in Finland and is primarily listed on the Nasdaq Helsinki exchange. As specific segment and geographic breakdowns are not provided, the company is described at the industry level as a participant in the commodity chemicals market.
Analyst recommendations
3 analysts · consensus HoldAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Orthex Oyj (ORTHEX.HE) is a Finnish company operating in the commodity chemicals industry within the broader chemicals sector. The firm is headquartered in Finland and is primarily listed on the Nasdaq Helsinki exchange. As specific segment and geographic breakdowns are not provided, the company is described at the industry level as a participant in the commodity chemicals market.
Orthex Oyj maintains a market capitalization of EUR 76.72 million and a price-to-earnings ratio of 49.08, indicating a relatively high valuation compared to its earnings. The company's price-to-book ratio of 2.2 suggests that the market values the company at twice its book value, which is a common multiple in the chemicals industry. The enterprise value to EBITDA ratio of 33.59 is significantly higher than the typical range for commodity chemicals, indicating that the company is trading at a premium relative to its operating performance.
In terms of profitability, Orthex reports a return on equity of 4.48% and a return on assets of 1.83%, both of which are below the industry median for commodity chemicals. The company's operating margin is 12.54% (calculated as operating income of EUR 2.76 million divided by revenue of EUR 22.01 million), which is also below the industry average. This suggests that Orthex is underperforming its peers in terms of generating returns from its equity and assets.
Orthex's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. The company's exposure to a single segment increases its vulnerability to market fluctuations in the chemicals industry. There is no information available on geographic revenue distribution, which limits the ability to assess regional risk exposure.
Looking at the company's growth trajectory, there is no specific outlook provided for the current or next fiscal year. However, the company's free cash flow of EUR 1.58 million and operating cash flow of EUR 4.07 million indicate a positive cash flow position, which supports operational flexibility. The capital expenditure of EUR -1.04 million suggests that the company is not currently investing heavily in new projects or infrastructure.
The risk assessment for Orthex highlights a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio of 0.86 indicates a moderate level of leverage, and the current ratio of 2.06 suggests that it has sufficient short-term assets to cover its short-term liabilities. However, the note that net cash is negative after subtracting total debt raises concerns about the company's liquidity position.
Recent events and disclosures for Orthex include analyst estimates that suggest a mean price target of EUR 5.30, with a median of EUR 5.30 and a range from EUR 5.00 to EUR 5.60. The mean recommendation from analysts is 2.67, indicating a generally positive outlook, with one strong-buy and one hold recommendation.
- Orthex Oyj is valued at a premium relative to its earnings and book value, with a P/E ratio of 49.08 and a P/B ratio of 2.2.
- The company's return on equity and return on assets are below the industry median, indicating underperformance in profitability.
- Orthex's revenue is concentrated in a single business segment, increasing its exposure to market volatility.
- Analysts have a generally positive outlook, with a mean price target of EUR 5.30 and a mean recommendation of 2.67.
- The company has a moderate level of leverage and a current ratio of 2.06, suggesting acceptable short-term liquidity.
Bull / Bear case
Generated · model-assistedFree cash flow surged nearly 100% year-over-year to EUR 5.1 million, demonstrating strong cash generation capabilities.
Analysts project 21.8% upside to a mean price target of EUR 5.30, suggesting undervaluation relative to current market price.
Cash conversion ratio of 2.61 ranks in the top quartile, outperforming the 1.1 cohort median significantly.
Long-term debt decreased steadily from EUR 35.5 million in 2022 to EUR 24.5 million in 2026, reducing leverage.
The company faces high credit risk, posing a significant threat to financial stability and potential borrowing costs.
Debt-to-equity ratio of 0.86 places Orthex in the bottom quartile, indicating excessive leverage compared to peers.
Revenue declined 2.8% year-over-year to EUR 87.2 million, reflecting a contraction in top-line growth.
Medium liquidity risk flags potential difficulties in meeting short-term obligations or managing cash flow volatility.
Return on equity of 4.5% remains modest, suggesting limited efficiency in generating profits from shareholder capital.
In focus — financials by report
Revenue €22.3M, −6,6% YoY; Operating income +10,1% YoY.
- ▍Revenue €22.3M, −6,6% YoY
- ▍Operating income +10,1% YoY
- ▍Net income +18,7% YoY
- ▍Free cash flow +7 600,0% YoY
- ▍Net margin 9.7%
Revenue €23.4M, +2,5% YoY; Operating income +19,5% YoY.
- ▍Revenue €23.4M, +2,5% YoY
- ▍Operating income +19,5% YoY
- ▍Net income +34,5% YoY
- ▍Free cash flow +92,0% YoY
- ▍Net margin 10.4%
Revenue €20.5M, −2,3% YoY; Operating income +10,9% YoY.
- ▍Revenue €20.5M, −2,3% YoY
- ▍Operating income +10,9% YoY
- ▍Net income −3,5% YoY
- ▍Free cash flow +70,1% YoY
- ▍Net margin 4.4%
Revenue €21.0M, −4,7% YoY; Operating income −37,8% YoY.
- ▍Revenue €21.0M, −4,7% YoY
- ▍Operating income −37,8% YoY
- ▍Net income −16,8% YoY
- ▍Free cash flow +13,9% YoY
- ▍Net margin 6.2%
Revenue €23.9M; Operating income €2.7M.
- ▍Revenue €23.9M
- ▍Operating income €2.7M
- ▍Net margin 7.6%
Revenue €22.8M; Operating income €2.8M.
- ▍Revenue €22.8M
- ▍Operating income €2.8M
- ▍Net margin 7.9%
Revenue €21.0M; Operating income €1.6M.
- ▍Revenue €21.0M
- ▍Operating income €1.6M
- ▍Net margin 4.4%
Revenue €22.0M; Operating income €2.8M.
- ▍Revenue €22.0M
- ▍Operating income €2.8M
- ▍Net margin 7.1%
Revenue €87.2M, −2,8% YoY; Operating income −0,5% YoY.
- ▍Revenue €87.2M, −2,8% YoY
- ▍Operating income −0,5% YoY
- ▍Net income +10,9% YoY
- ▍Free cash flow +99,9% YoY
- ▍Net margin 7.8%
Revenue €89.7M, +4,4% YoY; Operating income −8,5% YoY.
- ▍Revenue €89.7M, +4,4% YoY
- ▍Operating income −8,5% YoY
- ▍Net income −11,3% YoY
- ▍Free cash flow −60,7% YoY
- ▍Net margin 6.8%
Revenue €85.9M, +2,3% YoY; Operating income +107,1% YoY.
- ▍Revenue €85.9M, +2,3% YoY
- ▍Operating income +107,1% YoY
- ▍Net income +224,9% YoY
- ▍Free cash flow +156,2% YoY
- ▍Net margin 8.0%
Revenue €84.0M, −5,2% YoY; Operating income −43,9% YoY.
- ▍Revenue €84.0M, −5,2% YoY
- ▍Operating income −43,9% YoY
- ▍Net income −64,9% YoY
- ▍Free cash flow −51,4% YoY
- ▍Net margin 2.5%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,32 |
| Revenue | —no estimate | —no estimate | 90,8M EUR |
| Operating income | —no estimate | —no estimate | 10,5M EUR |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Orthex Oyj Market data — financials · 2026-05-28
- Orthex Oyj Market data — analyst estimates · 2026-05-28